The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

CDK2AP1  -  cyclin-dependent kinase 2 associated...

Homo sapiens

Synonyms: CDK2-associated protein 1, CDKAP1, Cyclin-dependent kinase 2-associated protein 1, DOC-1, DOC1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CDK2AP1

 

High impact information on CDK2AP1

 

Biological context of CDK2AP1

  • Therefore, identification of other p12(DOC-1/CDK2AP1) interacting proteins might clarify its role in the cell cycle regulation and carcinogenesis [10].
  • Using human p12(DOC-1/CDK2AP1) as a bait in a liver cDNA library screening, cDNA clones identical to human DOC-1R transcript were identified [10].
  • We have identified a novel gene from chromosome 11q13, which encodes a protein of 126 amino acids sharing an overall 57% identity with the p12(DOC-1) protein encoded by the DOC-1 gene, the human homolog of hamster putative tumor suppressor doc-1 (deleted in oral cancer-1) [11].
  • We also observed alterations in the biologic behavior of p12(DOC-1)-deficient cell lines, with increased S phase and decreased apoptosis compared to microsatellite-stable (DOC-1+) cell lines [3].
  • DOC-1 expression correlated with microsatellite status, with significantly decreased expression in microsatellite-unstable cell lines and constitutive expression in microsatellite-stable cell lines [3].
 

Anatomical context of CDK2AP1

 

Associations of CDK2AP1 with chemical compounds

 

Physical interactions of CDK2AP1

  • The loss of stable p21(WAF1)/cyclin E/CDK2 complexes coincided with an increase in CDK2-associated kinase activity and cyclin E levels [16].
  • These findings suggest that the overexpression of cyclin E reverses the p27(Kip1) mediated G1 growth arrest by binding the inhibitor restoring the cdk2 associated kinase activity necessary for the G1/S transition [17].
 

Regulatory relationships of CDK2AP1

 

Other interactions of CDK2AP1

  • Thus CGP 41251 inhibits CDC2- and CDK2-associated kinase activities both in vivo and in vitro [18].
  • RA-induced cell cycle arrest is also associated with induction of p27Kip1 expression, inhibition of cdk2-associated kinase activity and alteration of the phosphorylation state of the pRB-family proteins [19].
  • Ectopic overexpression of p21cip1/waf1 was associated with inhibition of CDK2-associated kinase activity, indicating the functionality of the introduced p21cip1/waf1 gene [20].
  • Interestingly, when wild-type MMR protein - MLH1 - was induced in an in vitro human recombinant system, the del T poly (T)8 mutation was reversed and CDK2-AP1 expression increased [21].
  • There were 27 "3-set" genotypes, 24 multilocus sequence types (STs), and 35 unique combinations (or strains), of which the 4 most common, msst III-2 (ST-17), msst III-1 (ST-19), Ia-1 (ST-23), and V-1 (ST-1), accounted for more than 60% of isolates [22].
 

Analytical, diagnostic and therapeutic context of CDK2AP1

References

  1. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Müller-Tidow, C., Metzger, R., Kügler, K., Diederichs, S., Idos, G., Thomas, M., Dockhorn-Dworniczak, B., Schneider, P.M., Koeffler, H.P., Berdel, W.E., Serve, H. Cancer Res. (2001) [Pubmed]
  2. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. Deng, L., Ammosova, T., Pumfery, A., Kashanchi, F., Nekhai, S. J. Biol. Chem. (2002) [Pubmed]
  3. Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer. Yuan, Z., Sotsky Kent, T., Weber, T.K. Oncogene (2003) [Pubmed]
  4. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Shintani, S., Mihara, M., Terakado, N., Nakahara, Y., Matsumura, T., Kohno, Y., Ohyama, H., McBride, J., Kent, R., Todd, R., Tsuji, T., Wong, D.T. Clin. Cancer Res. (2001) [Pubmed]
  5. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster, J.S., Henley, D.C., Bukovsky, A., Seth, P., Wimalasena, J. Mol. Cell. Biol. (2001) [Pubmed]
  6. p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein. Shintani, S., Ohyama, H., Zhang, X., McBride, J., Matsuo, K., Tsuji, T., Hu, M.G., Hu, G., Kohno, Y., Lerman, M., Todd, R., Wong, D.T. Mol. Cell. Biol. (2000) [Pubmed]
  7. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Gray-Bablin, J., Rao, S., Keyomarsi, K. Cancer Res. (1997) [Pubmed]
  8. Repression of G0/G1 traverse in human fibroblasts exposed to low levels of ionizing radiation. Wharton, W. J. Biol. Chem. (2004) [Pubmed]
  9. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex. Diederichs, S., Bäumer, N., Ji, P., Metzelder, S.K., Idos, G.E., Cauvet, T., Wang, W., Möller, M., Pierschalski, S., Gromoll, J., Schrader, M.G., Koeffler, H.P., Berdel, W.E., Serve, H., Müller-Tidow, C. J. Biol. Chem. (2004) [Pubmed]
  10. Interaction of the CDK2-associated protein-1, p12(DOC-1/CDK2AP1), with its homolog, p14(DOC-1R). Buajeeb, W., Zhang, X., Ohyama, H., Han, D., Surarit, R., Kim, Y., Wong, D.T. Biochem. Biophys. Res. Commun. (2004) [Pubmed]
  11. Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene. Zhang, X., Tsao, H., Tsuji, T., Minoshima, S., McBride, J., Majewski, P., Todd, R., Shimizu, N., Wong, D.T., Housman, D.E., Haluska, F.G. Biochem. Biophys. Res. Commun. (1999) [Pubmed]
  12. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Bortner, D.M., Rosenberg, M.P. Cell Growth Differ. (1995) [Pubmed]
  13. doc-1--mediated apoptosis in malignant hamster oral keratinocytes. Cwikla, S.J., Tsuji, T., McBride, J., Wong, D.T., Todd, R. J. Oral Maxillofac. Surg. (2000) [Pubmed]
  14. Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells. Mou, S., Linnekin, D. Biochem. J. (1999) [Pubmed]
  15. Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis. Eiras, S., Fernández, P., Piñeiro, R., Iglesias, M.J., González-Juanatey, J.R., Lago, F. Cardiovasc. Res. (2006) [Pubmed]
  16. Adeno-Associated Virus Type 2 Increases Proteosome-Dependent Degradation of p21WAF1 in a Human Papillomavirus Type 31b-Positive Cervical Carcinoma Line. Alam, S., Sen, E., Brashear, H., Meyers, C. J. Virol. (2006) [Pubmed]
  17. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells. Kwon, T.K., Nordin, A.A. Biochem. Biophys. Res. Commun. (1997) [Pubmed]
  18. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity. Begemann, M., Kashimawo, S.A., Heitjan, D.F., Schiff, P.B., Bruce, J.N., Weinstein, I.B. Anticancer Res. (1998) [Pubmed]
  19. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Dirks, P.B., Patel, K., Hubbard, S.L., Ackerley, C., Hamel, P.A., Rutka, J.T. Oncogene (1997) [Pubmed]
  20. Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells. Izawa, H., Yamamoto, H., Damdinsuren, B., Ikeda, K., Tsujie, M., Suzuki, R., Kitani, K., Seki, Y., Hayashi, T., Takemasa, I., Ikeda, M., Ohue, M., Sekimoto, M., Monden, T., Monden, M. Int. J. Oncol. (2005) [Pubmed]
  21. Modulation of CDK2-AP1 (p12(DOC-1)) expression in human colorectal cancer. Yuan, Z., Gaba, A.G., Kent, T.S., Bennett, A., Miller, A., Weber, T.K. Oncogene (2005) [Pubmed]
  22. Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (Group B Streptococcus). Sun, Y., Kong, F., Zhao, Z., Gilbert, G.L. J. Clin. Microbiol. (2005) [Pubmed]
  23. Isolation, mapping and mutation analysis of a human cDNA homologous to the doc-1 gene of the Chinese hamster, a candidate tumor suppressor for oral cancer. Daigo, Y., Suzuki, K., Maruyama, O., Miyoshi, Y., Yasuda, T., Kabuto, T., Imaoka, S., Fujiwara, T., Takahashi, E., Fujino, M.A., Nakamura, Y. Genes Chromosomes Cancer (1997) [Pubmed]
 
WikiGenes - Universities